España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Stock Trading Ideas
Greed Mode On: Why Tesla, Nvidia, Palantir And Bitcoin Plays Could Rip
Forget Robotaxis - Ford Just Drove Straight Into Tesla's Valuation Problem
Nvidia's $4T Countdown: Will Next Week's Chart Print A Trillion-Dollar Breakout?
Forget Robotaxis - Ford Just Drove Straight Into Tesla's Valuation Problem
Nvidia's $4T Countdown: Will Next Week's Chart Print A Trillion-Dollar Breakout?
Stock Of The Day: Classic Flag Pattern In Coinbase?
Walmart, Peloton, Chewy Set To Steal Amazon's Prime Day — Again
Stock Of The Day: Classic Flag Pattern In Coinbase?
Walmart, Peloton, Chewy Set To Steal Amazon's Prime Day — Again
Cybertruck Dreams Shatter As Musk's 250K Goal Unravels
The Inverse Cramer AI Play: How Nebius Combines Tesla Vibes With Nvidia Muscle
Read More...
Trading Ideas Recent News
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers during the week and a look at the potential catalysts driving momentum.
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
Royal Caribbean Cruises Stock Up 0.9% After Key Trading Signal
A significant trading signal occurred for Royal Caribbean Cruises stock at a price of $331.57, after which RCL rose up to 0.9%.
Quantum Stock Watch: Bullish Analyst Coverage On IonQ, D-Wave, Rigetti Computing
Quantum computing stocks had a big week with a completed offering and bullish analyst coverage of several stocks.
3 Defense Stocks To Buy With The Middle East In Turmoil
The S&P 500 Sank 10% The Last Time This Warning Flashed
The S&P 500 tops 6,300 before July 4, but overbought RSI levels raise red flags for a potential pullback.
Soft US Jobs Report, Rate Cut Hopes May Bring Dividend ETFs Back In Style
Dividend ETFs like SCHD and VYM could gain favor as soft jobs data fuels Fed cut bets, making equity income strategies shine again.
Constellation Brands Analysts Boost Their Forecasts After Q1 Results
Crude Oil Down 1%; Tripadvisor Shares Jump
This Is Netflix's Next Big Bet After 'Squid Game,' 'Stranger Things'
Netflix is putting an increased emphasis on new entertainment content such as awards shows, live concerts, reality competitions and more.
How I'm Trading 2025's Biggest Winners And Losers
Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday